Revolution MD
[Closed for Investment] Revolution MD, with a valuation of $26.7 million, is raising funds on StartEngine. The company is reinventing medication delivery with its patent-pending smart inhaler. The inhaler, INHALE, is safely designed to control the dispensing of opioids and provide immediate pain relief along with minimizing the risk of addiction. Revolution MD plans to submit the pre-IND to the FDA and complete the device for clinical trials. Josh Kimmel founded Revolution MD in August 2018. The current crowdfunding campaign has a minimum target of $10,000 and a maximum target of $1,070,000. The campaign proceeds will be used for FDA approvals and clinical trials.
Investment Overview
Raised: $59,322
Deal Terms
Total Commitments ($USD)
- Platform
- StartEngine
- Start Date
- 12/31/2021
- Close Date
- 07/28/2022
$10,000
$1,070,000
$250
Equity - Common
Pre-Seed
RegCF
$2.00
$26,712,500
Company & Team
Company
- Year Founded
- 2018
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B
- Margin
- Medium
- Capital Intensity
- Low
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 07/28/2022 | StartEngine | $26,712,500 | $59,322 | Equity - Common | Funded | RegCF |